Which variables are associated with blood glucose levels outside the target range in surgical critically ill patients? A retrospective observational study

Patient Safety in Surgery

Volumn 5, Issue 1, 2011, Pages

  Weiss, Manfred ^a   Kron, Martina ^b   Hay, Birgit ^b   Taenzer, Michael ^a   Radermacher, Peter ^a   Georgieff, Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955401049     PISSN: None     EISSN: 17549493     Source Type: Journal    
DOI: 10.1186/1754-9493-5-5     Document Type: Article

References (36)

1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30(4):536-555. 10.1007/s00134-004-2210-z, 14997291.
2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34(1):17-60. 10.1007/s00134-007-0934-2, 2249616, 18058085.
3. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345(19):1359-1367. 10.1056/NEJMoa011300, 11794168.
4. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354(5):449-461. 10.1056/NEJMoa052521, 16452557.
5. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360(13):1283-1297. 10.1056/NEJMoa0810625, 19318384.
6. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358(2):125-139. 10.1056/NEJMoa070716, 18184958.
7. Schultz MJ, Harmsen RE, Spronk P. Clinical review: strict or loose glycemic control in critically ill patients - implementing the best available evidence from randomized controlled trials. Crit Care 2010, 14(223).
8. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180(8):821-827. 10.1503/cmaj.090206, 2665940, 19318387.
9. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105(2):244-252. 10.1097/00000542-200608000-00006, 16871057.
10. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 2009, 37(9):2536-2544. 10.1097/CCM.0b013e3181a381ad, 19623047.
11. Ali NA, O'Brien JM, Dungan K, Phillips G, Marsh CB, Lemeshow S, Connors AF, Preiser JC. Glucose variability and mortality in patients with sepsis. Crit Care Med 2008, 36(8):2316-2321. 10.1097/CCM.0b013e3181810378, 18596625.
12. Diamond MP, Jones T, Caprio S, Hallarman L, Diamond MC, Addabbo M, Tamborlane WV, Sherwin RS. Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism 1993, 42(12):1568-1572. 10.1016/0026-0495(93)90152-E, 8246771.
13. Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest 2004, 126(3):879-887. 10.1378/chest.126.3.879, 15364770.
14. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007, 35(10):2262-2267. 10.1097/01.CCM.0000282073.98414.4B, 17717490.
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29(4):530-538.
16. Atkinson M, Worthley LI. Nutrition in the critically ill patient: part I. Essential physiology and pathophysiology. Crit Care Resusc 2003, 5(2):109-120.
17. Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ, Hoekstra JB. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 2006, 34(1):96-101. 10.1097/01.CCM.0000194536.89694.06, 16374162.
18. Watters JM, Bessey PQ, Dinarello CA, Wolff SM, Wilmore DW. Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg 1986, 121(2):179-190.
19. Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care 2007, 11(1):R21. 10.1186/cc5696, 2151907, 17306016.
20. Weber-Carstens S, Deja M, Bercker S, Dimroth A, Ahlers O, Kaisers U, Keh D. Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients. Intensive Care Med 2007, 33(4):730-733. 10.1007/s00134-007-0540-3, 17325831.
21. Gearhart MM, Parbhoo SK. Hyperglycemia in the critically ill patient. AACN Clin Issues 2006, 17(1):50-55. 10.1097/00044067-200601000-00007, 16462409.
22. Reinelt H, Radermacher P, Kiefer P, Fischer G, Wachter U, Vogt J, Georgieff M. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 1999, 27(2):325-331. 10.1097/00003246-199902000-00039, 10075057.
23. Le-Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270(24):2957-2963. 10.1001/jama.270.24.2957, 8254858.
24. Bone RC. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042.
25. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33(2):464-470. 10.1053/jhep.2001.22172, 11172350.
26. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26(11):1793-1800.
27. Weiss M, Huber-Lang M, Taenzer M, Traeger K, Altherr J, Kron M, Hay B, Schneider M. Different patient case mix by applying the 2003 SCCM/ESICM/ACCP/ATS/SIS sepsis definitions instead of the 1992 ACCP/SCCM sepsis definitions in surgical patients: a retrospective observational study. BMC Med Inform Decis Mak 2009, 9:25. 10.1186/1472-6947-9-25, 2698820, 19450242.
28. Roth BL, Spitzer JA. Altered hepatic vasopressin and alpha 1-adrenergic receptors after chronic endotoxin infusion. Am J Physiol 1987, 252(5 Pt 1):E699-702.
29. Hillenbrand A, Knippschild U, Weiss M, Schrezenmeier H, Henne-Bruns D, Huber-Lang M, Wolf AM. Adipose tissue derived hormones in septic patients. BMC Surgery 2010, 10:26. 10.1186/1471-2482-10-26, 2944119, 20825686.
30. Hillenbrand A, Weiss M, Knippschild U, Stromeyer HG, Henne-Bruns D, Huber-Lang M, Wolf AM. Association of adiponectin levels and insulin demand in critically ill patients. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:45-51. 10.2147/DMSO.S15211, 3064412, 21448321.
31. Walrand S, Guillet C, Boirie Y, Vasson MP. Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans. J Clin Endocrinol Metab 2006, 91(7):2738-2748. 10.1210/jc.2005-1619, 16621902.
32. De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE, Bedoya M, Toro JM, Velasquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008, 12(5):R120. 10.1186/cc7017, 2592751, 18799004.
33. Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chiolero R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35(10):1738-1748. 10.1007/s00134-009-1585-2, 19636533.
34. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006, 55(11):3151-3159. 10.2337/db06-0855, 17065355.
35. Rabinstein AA. Hyperglycemia in critical illness: lessons from NICE-SUGAR. Neurocrit Care 2009, 11(1):131-132. 10.1007/s12028-009-9240-x, 19499351.
36. Bellomo R, Egi M. What is a NICE-SUGAR for patients in the intensive care unit?. Mayo Clin Proc 2009, 84(5):400-402. 10.4065/84.5.400, 2676121, 19411435.